"use strict";(self.webpackChunkBenStockTracker=self.webpackChunkBenStockTracker||[]).push([[207],{207:e=>{e.exports=JSON.parse('{"a6f7a67d-64ad-3d8c-97ba-74f7a40d7417":{"uuid":"a6f7a67d-64ad-3d8c-97ba-74f7a40d7417","title":"Pfizer Tumbles On Lackluster Outlook Despite A Covid-Driven Quarterly Beat","publisher":"Investor\'s Business Daily","link":"https://finance.yahoo.com/m/a6f7a67d-64ad-3d8c-97ba-74f7a40d7417/pfizer-tumbles-on-lackluster.html","providerPublishTime":1659039989,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/qt8DMg8s2ihAm.YwGHllTQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/.BHijbmWvMVqx76V_iGlBQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/3dffc435f585895e4f9c02c947878503","width":1000,"height":563,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/KlYAY2STXbkjKyPovVDJPA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/.BHijbmWvMVqx76V_iGlBQ--~B/aD01NjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/3dffc435f585895e4f9c02c947878503","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["PFE"]},"8ba47b15-0850-3c57-917a-572919ab8345":{"uuid":"8ba47b15-0850-3c57-917a-572919ab8345","title":"Pfizer\u2019s Updated Covid-19 Booster Will \u2018Likely\u2019 Be Ready in Early Fall, CEO Says","publisher":"Barrons.com","link":"https://finance.yahoo.com/m/8ba47b15-0850-3c57-917a-572919ab8345/pfizer%E2%80%99s-updated-covid-19.html","providerPublishTime":1659038160,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/aQDvNjPkF03mKs6P.8oMPw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/ElcGcev6_KNzsc62g2s6zw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/abd54c5804bc5509984a163bb4465dcd","width":1280,"height":640,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/R4rzSADimtZQC8egW.HKKA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/ElcGcev6_KNzsc62g2s6zw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/abd54c5804bc5509984a163bb4465dcd","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["PFE","MRNA"]},"fe038b68-bc87-3cf0-8819-1db615692604":{"uuid":"fe038b68-bc87-3cf0-8819-1db615692604","title":"Pfizer Sales Climb Again on Covid-19 Products","publisher":"The Wall Street Journal","link":"https://finance.yahoo.com/m/fe038b68-bc87-3cf0-8819-1db615692604/pfizer-sales-climb-again-on.html","providerPublishTime":1659036360,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/wv8A81dkMbRTycxfTZbEsQ--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/4jPONrVz6DXgRJqU5bmxPw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/91aceae47a1b6a3ac4a5f50147ae0b44","width":1280,"height":640,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/JqaLnTvCTiAbPMEC8CJBXA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/4jPONrVz6DXgRJqU5bmxPw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/91aceae47a1b6a3ac4a5f50147ae0b44","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["BNTX","PFE"]},"b7a7db2c-6a2b-3cbf-87d4-1ed21966f7ee":{"uuid":"b7a7db2c-6a2b-3cbf-87d4-1ed21966f7ee","title":"Pfizer Raises Earnings Outlook Even as Covid-Era Supply Deals Slow","publisher":"Bloomberg","link":"https://finance.yahoo.com/news/pfizer-raises-earnings-outlook-even-134418626.html","providerPublishTime":1659036324,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/3RHud0AdvRwdLJc0tLptEQ--~B/aD0xMzMzO3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://s.yimg.com/uu/api/res/1.2/03hLXUDGa9yEQaDAV74bLA--~B/aD0xMzMzO3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_markets_842/bb7827c3ebfe0062d902daf06ff02cc2","width":2000,"height":1333,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/9rAiiJFv6nswWbzMlVCFZA--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/03hLXUDGa9yEQaDAV74bLA--~B/aD0xMzMzO3c9MjAwMDthcHBpZD15dGFjaHlvbg--/https://media.zenfs.com/en/bloomberg_markets_842/bb7827c3ebfe0062d902daf06ff02cc2","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["PFE"]},"1060e02f-41a4-319a-a011-70ffede3eaca":{"uuid":"1060e02f-41a4-319a-a011-70ffede3eaca","title":"Pharma Is Immune to a Recession, but Not to Washington","publisher":"The Wall Street Journal","link":"https://finance.yahoo.com/m/1060e02f-41a4-319a-a011-70ffede3eaca/pharma-is-immune-to-a.html","providerPublishTime":1659030600,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/C4yfU0ibRFemwFfXmx36mg--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/2KjxvsvZpngSIRsd.XTZsA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/3fc1109fd8ab4559537331a499d1e4f5","width":1280,"height":640,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/vLCdCMVoV.dJJKoOh0GZ.w--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/2KjxvsvZpngSIRsd.XTZsA--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/wsj.com/3fc1109fd8ab4559537331a499d1e4f5","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["BMY","PFE"]},"9a6f7dfd-febf-37fb-912a-e0504d778fbc":{"uuid":"9a6f7dfd-febf-37fb-912a-e0504d778fbc","title":"Is Pfizer Stock A Sell On More Moderate Expectations For 2022 Sales?","publisher":"Investor\'s Business Daily","link":"https://finance.yahoo.com/m/9a6f7dfd-febf-37fb-912a-e0504d778fbc/is-pfizer-stock-a-sell-on.html","providerPublishTime":1659029239,"type":"STORY","thumbnail":{"resolutions":[{"url":"https://s.yimg.com/uu/api/res/1.2/aL0JwQMm.inZ1aCmR2jyfg--~B/aD02MDA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/VXlE44YwXg8AwqPI_gImww--~B/aD02MDA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f30299e3b2fb410e4254157268387d26","width":1065,"height":600,"tag":"original"},{"url":"https://s.yimg.com/uu/api/res/1.2/UGNMzQYKLnvtV4azlBFt5Q--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://s.yimg.com/uu/api/res/1.2/VXlE44YwXg8AwqPI_gImww--~B/aD02MDA7dz0xMDY1O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/ibd.com/f30299e3b2fb410e4254157268387d26","width":140,"height":140,"tag":"140x140"}]},"relatedTickers":["PFE"]},"9aa73ebf-b0d3-3812-9a36-e83393b61eeb":{"uuid":"9aa73ebf-b0d3-3812-9a36-e83393b61eeb","title":"Pfizer Earnings: What Happened with PFE","publisher":"Investopedia","link":"https://finance.yahoo.com/m/9aa73ebf-b0d3-3812-9a36-e83393b61eeb/pfizer-earnings%3A-what.html","providerPublishTime":1659026857,"type":"STORY","relatedTickers":["PFE"]},"ee6548ce-9cb0-3c10-a628-9972bea48fa2":{"uuid":"ee6548ce-9cb0-3c10-a628-9972bea48fa2","title":"2 Ultra-Safe Dividend Stocks With Extremely Low Payout Ratios","publisher":"Motley Fool","link":"https://finance.yahoo.com/m/ee6548ce-9cb0-3c10-a628-9972bea48fa2/2-ultra-safe-dividend-stocks.html","providerPublishTime":1659022200,"type":"STORY","relatedTickers":["PFE","COST"]}}')}}]);